Day: April 8, 2020

MISSISSAUGA, Ontario, April 08, 2020 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX:KPT), which holds a limited partnership interest in Kruger Products L.P. (“KPLP”), will release the financial results for KPT and KPLP for the first quarter of 2020 on Friday, May 8 before the market opens. KPT will hold its conference call the same day at 8:30 a.m. Eastern Time.Details of the Conference CallVia telephone: 1- 877-223-4471 or 647-788-4922Via the internet at: www.kptissueinc.comPresentation material referenced during the conference call will be available at www.kptissueinc.com.Conference Call RebroadcastA rebroadcast of the conference call will be available until midnight, May 15, 2020 by dialing 1-800-585-8367 or 416-621-4642 and entering passcode­­ 6936809.The replay of the webcast will remain available on the web site until midnight,...

MISSISSAUGA, Ontario, 08 avr. 2020 (GLOBE NEWSWIRE) — Papiers Tissu KP inc. (TSX : KPT) (« PTKP »), qui détient un intérêt limité dans Produits Kruger S.E.C (« PK S.E.C. »), publiera les résultats financiers de PTKP et de PK S.E.C. pour le premier trimestre de l’exercice 2020 le vendredi 8 mai 2020, avant l’ouverture de la séance. PTKP tiendra une téléconférence cette même journée, à 8 h 30, heure de l’Est.Renseignements sur la téléconférence (en anglais seulement)Au téléphone : 1- 877-223-4471 ou 647-788-4922Sur le site Web : www.kptissueinc.comLes documents auxquels on fera référence lors de la téléconférence seront disponibles au www.kptissueinc.com.Téléconférence archivéeLa téléconférence sera disponible jusqu’à minuit le 15 mai 2020 et il sera possible d’y accéder en composant le 1-800-585-8367 ou le 416-621-4642 et en...

IRVINE, Calif., April 08, 2020 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a fast-growing technology-enabled Japanese restaurant concept, today announced that it will host a conference call to discuss second quarter 2020 financial results on Tuesday, April 14th, 2020 at 5:00 p.m. ET. A press release with second quarter 2020 financial results will be issued that same day after the market close.  Hosting the conference call and webcast will be Hajime “Jimmy” Uba, President and Chief Executive Officer, and Koji Shinohara, Chief Financial Officer.Interested parties may listen to the conference call via telephone by dialing 201-689-8471. A telephone replay will be available shortly after the call has concluded and can be accessed by dialing 412-317-6671; the passcode is 13701829.The webcast...

MONTREAL, April 08, 2020 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) is pleased to announce that the pan-Canadian Pharmaceutical Alliance (pCPA) price negotiations for Triamcinolone Hexacetonide Injectable Suspension 20mg/mL (TH) in Canada are completed with expected public reimbursement to roll out in the respective provinces over the coming months.TH is the longest acting corticosteroid for intra articular injection, often lasting twice as long as competitive products. Health Canada previously approved TH in December 2017 for intra-articular, intrasynovial, or periarticular use in adults and adolescents for the symptomatic treatment of subacute and chronic inflammatory joint diseases including: rheumatoid arthritis, juvenile idiopathic arthritis (JIA), osteoarthritis,...

ANDOVER, Mass., April 08, 2020 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, announced today that, due to the public health impact of the novel coronavirus (COVID-19) and governmental restrictions limiting the number of people who may gather together, and to support the health and well-being of its shareholders and company personnel, it will change the date of its annual meeting of shareholders to Monday, May 11, 2020 and will hold this meeting via remote communication only. Shareholders will be able to participate in the annual meeting of shareholders only via the virtual meeting. As previously announced, the meeting will be held at 10:00 a.m. Eastern Time.As described in the proxy materials for the annual meeting of shareholders...

WARREN, N.J., April 08, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to study the INOpulse® inhaled nitric oxide system (iNO) for the treatment of patients infected with COVID-19. INOpulse is the only therapy to deliver targeted nitric oxide by autonomously adjusting to the patient’s breathing pattern to ensure accurate and consistent drug delivery into the airways. The proposed randomized, open-label study, called PULSE-CVD19-001, will evaluate the efficacy and safety of INOpulse in patients with COVID-19 who require supplemental oxygen. The PULSE-CVD19-001 protocol utilizes...

SALT LAKE CITY, April 08, 2020 (GLOBE NEWSWIRE) — Overstock.com, Inc. (NASDAQ:OSTK) announces that, as expected, The Depository Trust Company (DTC) granted eligibility to the company’s Digital Voting Series A-1 Preferred Stock, OSTKO, on April 7, 2020. DTC eligibility allows shares of OSTKO to be eligible for depository and book-entry services at DTC. “This is a long-awaited moment for Overstock and our shareholders, as DTC’s grant of eligibility removes a hurdle to issuing our innovative digital dividend,” said Overstock CEO Jonathan Johnson. “DTC eligibility will make the dividend easier for broker dealers to process on behalf of our shareholders.”Overstock expects NASDAQ to issue an ex-dividend date in the coming days.The company continues to provide detailed information on the divided, including a timeline and answers to frequently...

COS COB, Conn., April 08, 2020 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced that the Crackle Original basketball docuseries On Point has driven over 12 million views since its February 13th launch.The 10-part docuseries offers a behind-the-scenes look at the high-stakes world of prep and Amateur Athletic Union (“AAU”) basketball, a proving ground for top NBA players for the last several decades. On Point spotlights Romeo Langford, who is now a member of the NBA’s Boston Celtics and Scottie Lewis, now at the University of Florida, among other talented young players. Notable appearances in the series include NBA stars Kevin Durant, Steph Curry, and Zion Williamson.“We are delighted with...

CAMBRIDGE, Mass., April 08, 2020 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the 19th Annual Needham Healthcare Conference. The conference is being conducted with a virtual format and the presentation will take place on Tuesday, April 14, 2020 at 1:30pm Eastern Time.A live webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.comAbout Vericel CorporationVericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes...

PHILADELPHIA, April 08, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that management will present at the virtual 19th Annual Needham Healthcare Conference on Wednesday, April 15, 2020 at 12:50pm ET.A live audio webcast of the presentation will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the webcast will be available for 30 days following the presentation.About Passage BioPassage Bio is a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company is based in Philadelphia, PA and...